Navigation Links
Vitamin D Use Linked to Lower Mortality in Kidney Patients
Date:5/16/2008

Study finds chronic disease sufferers gain benefit from calcitriol, an oral form

FRIDAY, May 16 (HealthDay News) -- Taking activated vitamin D may cut the risk of death for people with moderate to severe chronic kidney disease by about one quarter, a new study suggests.

During a two-year study of more than 1,400 patients, those being treated with calcitriol, an oral form of activated vitamin D, had their overall risk of death lowered by 26 percent when compared with those not on the drug. Those taking calcitriol were also less likely to develop end-stage renal disease, which requires dialysis to replace lost kidney function.

Patients with advanced chronic kidney disease (CKD) often take calcitriol to treat elevated levels of parathyroid hormone (hyperparathyroidism), a condition that can weaken the bones.

"Although activated vitamin D is known to influence many biological processes, previous clinical knowledge is limited to its effect on parathyroid hormone levels," study co-author Dr. Bryan Kestenbaum, of the University of Washington in Seattle, said in a prepared statement.

Overall, calcitriol use was linked to a 20 percent reduction in the likelihood of either dying or needing dialysis. The reduction in mortality with calcitriol appeared to be unrelated to its effect on parathyroid hormone levels.

The study is published in the August issue of the Journal of the American Society of Nephrology.

The lack of data on other factors that may have improved survival rates in patients taking calcitriol does limit the study's conclusions, as does the narrow range of demographics among its subjects, the study added. Those studied were primarily older, white men, so the results are not guaranteed to repeat when treatment is given to a younger, more ethnically diverse population with chronic kidney disease (CKD).

"Randomized clinical trials are needed to test the hypothesis that vitamin D therapy can improve cardiovascular health and survival in CKD," Kestenbaum said. "Future studies should also examine the role of non-activated vitamin D, which is less expensive and less toxic."

More information

The U.S. National Library of Medicine has more about the causes and treatment of kidney failure.



-- Kevin McKeever



SOURCE: American Society of Nephrology, news release, May 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Study shines more light on benefit of vitamin D in fighting cancer
2. Vitamin Es lack of heart benefit linked to dosage
3. Fat transforms vitamin C from good cop into bad cop
4. Vitamin C Plus Fat Might Spur Cancer
5. How vitamin C stops the big C
6. Vitamin D Supplements May Lengthen Life
7. Joint Juice Launches New Ready-to-Drink Glucosamine & Vitamin-Enhanced Dietary Supplement Water Nationwide
8. Vitamin Relief Brings Needed Nutrition to School District Resurrecting After Katrina
9. Excessive Multivitamin Use May Raise Risk for Prostate Cancer, from Harvard Mens Health Watch
10. As Winter Approaches, Risk for Vitamin D Deficiency Increases
11. Vitamin D Wont Help Prevent Most Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... MA (PRWEB) , ... December 08, 2016 , ... ... Workers Compensation Research Institute (WCRI) officially opened registration today for its 33rd ... Hotel in Boston, MA . , The theme of the conference is “Persistent ...
(Date:12/8/2016)... PLAINS, N.Y., and JENNERSVILLE, Pa. (PRWEB) , ... ... ... to announce that Penn Medicine Southern Chester County, a Property owned by an ... The $23 million, 72,000 square foot Penn Medicine Southern Chester County ambulatory care ...
(Date:12/8/2016)... , ... December 08, 2016 , ... With the increasing ... the “What’s In Your Mouth?” (WIYM) campaign to inform dentists and patients about the ... the dental implant and prosthetic market in the U.S. is projected to reach $6.4 ...
(Date:12/8/2016)... ... 08, 2016 , ... SunView Software aims to redefine IT ... both engaging and easy to use. Coming off the heels of a successful ... its plans to roll out new AI-powered self-service enhancements to help organizations implement ...
(Date:12/8/2016)... ... December 08, 2016 , ... STATEN ... been recognized for adherence to the highest standards of trauma, maternity, cancer and ... the center's president and CEO, Dr. Daniel Messina. , Among the recognitions, the ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Diplomat Pharmacy, Inc. (NYSE: DPLO) has ... 2016 Top Workplaces National Standard. To learn ... ... (PRNewsFoto/Diplomat Pharmacy, Inc.) ... an employee survey administered by WorkplaceDynamics, LLC, a research firm specializing ...
(Date:12/8/2016)... 8, 2016  Eli Lilly and Company (NYSE: ... phase 3 EXPEDITION3 trial at the 9 th ... disclosed, solanezumab did not meet the primary endpoint in ... in people with mild dementia due to Alzheimer,s disease ... solanezumab for the treatment of mild dementia due to ...
(Date:12/8/2016)... DUBLIN , Dec 8, 2016 Research ... Electrodes Market Analysis and Trends - Adhesion Type, Application, Usability - ... ... The Global Cardiology Electrodes Market is poised to grow at a ... prominent trends that the market is witnessing include advancements in extracellular ...
Breaking Medicine Technology: